Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy

Phase 0 Unknown 100 enrolled Asmaa Ahmed Ali Youssif

Non-randomizedParallel-groupTriple-blindDiagnostic

Summary

* Reduce the trauma and the time taken for patient rehabilitation. * The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication. * Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.

Timeline

Start: 2020-12-01
Primary completion: 2021-12-01
Completion: 2022-03-01

Publications

Background He M, Wang W, Zhang X, Huang W. Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis. PLoS One. 2014 Jan 20;9(1):e85782. doi: 10.1371/journal.pone.0085782. eCollection 2014.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Mitomycin C	Other / unclassified	—	—

Indications

No indication recorded.